The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 98:397-400, November 1941
doi: 10.1176/appi.ajp.98.3.397
© 1941 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by COTTINGTON, F.
* Search for Related Content
PubMed
* Articles by COTTINGTON, F.

THE TREATMENT OF CHILDHOOD SCHIZOPHRENIA BY METRAZOL SHOCK MODIFIED BY B-ERYTHROIDIN

FRANCES COTTINGTON M. D.1

1 The children's division of the Bellevue Psychiatric Hospital and New York University Medical School.

The method of modification of the metrazol seizure by beta-erythroidin hydrochloride used by other investigators is here applied to the treatment of schizophrenic children, in whom the incidence of fractures sustained by unmodified metrazol convulsions appears high.

The physiological effect of the drug is discussed in its application to the diminution of strength of muscular contraction, and modification of the convulsion.

Modification of the seizures has resulted in preventing fractures in 9 of 1O cases, the tenth patient sustaining a fracture through a delayed, unmodified seizure. It is suggested that by avoidance of the use of prostigmine, the danger of this complication may be decreased. The safety of this method of modification is assured by careful technique of administration.

Clinical results show that 8 of 9 schizophrenic children treated (including two previously treated by unmodified shock) have shown improvement in response to metrazol therapy. Final evaluation of the efficacy of metrazol treatment in these cases must necessarily await further observations, to determine whether patients treated by this method show a better remission rate than the low figures for spontaneous remission indicate.







Get information about faster international access.

Privacy Policy

Copyright © 1941 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org